- World rank, 2022-now
- #18,124 of 22,385 · #16,950 all time
- Rank in United States
- #2,663 of 3,332
- Research works
- 146 ▲ 115% vs 2018-21
- Citations
- 1.8k 12.5 per fractional work
- Top-10% rate
- 26.2% all institutions 10.0%
- vs its own fields
- 1.08× 1.00× is exactly expected
- Open access
- 35% world 40%
- International
- 15% world 18%
Which fields of science does Revolution Medicines (United States) work in?
In 2022-now, 49% of research at Revolution Medicines (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (46%), Medicine (34%), Computer Science (4%). It does 3.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 19 fields, with their numbers
- Life Sciences4049.2%
- Health Sciences2834.1%
- Medicine2834.0%
- Health Professions00.1%
- Physical Sciences810.2%
- Computer Science33.7%
- Engineering22.3%
- Mathematics11.5%
- Materials Science11.4%
- Chemistry11.0%
- Environmental Science00.2%
- Social Sciences56.5%
What does Revolution Medicines (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 12.6× the share of its output that it takes of world research.
- Molecular BiologySubfield · 30.8 works13×
- Biochemistry, Genetics and Molecular BiologyField · 36.9 works8.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.6×. Every wedge is a field page.
All 19 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology8.56×37 works
- Immunology and Microbiology2.90×2 works
- Medicine1.77×28 works
- Mathematics1.26×1 works
- Decision Sciences1.17×1 works
- Pharmacology, Toxicology and Pharmaceutics0.64×0 works
- Chemistry0.62×1 works
- Arts and Humanities0.54×1 works
- Economics, Econometrics and Finance0.52×1 works
- Computer Science0.48×3 works
- Materials Science0.41×1 works
- Business, Management and Accounting0.32×1 works
- Engineering0.15×2 works
- Social Sciences0.13×1 works
- Agricultural and Biological Sciences0.08×0 works
- Neuroscience0.04×0 works
- Environmental Science0.04×0 works
- Health Professions0.04×0 works
- Psychology0.02×0 works
- Biochemistry, Genetics and Molecular Biology 8.6×
- Immunology and Microbiology 2.9×
- Medicine 1.8×
- Mathematics 1.3×
- Decision Sciences 1.2×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Chemistry 0.6×
- Arts and Humanities 0.5×
- Economics, Econometrics and Finance 0.5×
- Computer Science 0.5×
- Materials Science 0.4×
- Business, Management and Accounting 0.3×
- Engineering 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Neuroscience 0.0×
- Environmental Science 0.0×
- Health Professions 0.0×
- Psychology 0.0×
Who are the top researchers at Revolution Medicines (United States)?
Ranked on the quality score, Mallika Singh, Elsa Quintana and Zhican Wang lead among researchers whose main affiliation is Revolution Medicines (United States).
- 1
Mallika Singh
United States · #45,220 worldwide 9.1k citations · 375 works
- 2
Elsa Quintana
United States · #109,272 worldwide 5.9k citations · 268 works
- 3
Zhican Wang
United States · #131,617 worldwide 2.5k citations · 144 works
- 4
Nataliya Tovbis Shifrin
United States · #135,089 worldwide 2.6k citations · 115 works
- 5
David P. Wildes
United States · #143,040 worldwide 2.9k citations · 131 works
- 6
Yu Chi Yang
United States · #162,248 worldwide 3.9k citations · 112 works
- 7
Jacqueline A.M. Smith
United States · #174,840 worldwide 4.8k citations · 264 works
- 8
Aidan C.A. Tomlinson
United States · #196,099 worldwide 1.6k citations · 84 works
- 9
Adrian L. Gill
United States · #219,856 worldwide 3.4k citations · 156 works
- 10
Abby Marquez
United States · #222,222 worldwide 1.8k citations · 95 works
Which keywords describe research at Revolution Medicines (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Therapy, Tumor Microenvironment, Transcriptional Regulation, Cancer, Oncogenic Mutations, Cancer Progression, Chemotherapy and PET Imaging.
- Mutation
- mTOR
- Signaling
- Melanoma
- Ras Signaling
- Immune Response
- Molecular Chaperones
- Cell Proliferation
- N-terminal Acetylation
- Fibroblast Activation Protein
- NFAT
- Calcineurin
- Immune Checkpoint Blockade
- Proteasome
- Proteasome Inhibitors
- Angiogenesis
- Cell Signaling
- Cancer Progression
- Cancer
- Tumor Microenvironment
- Cancer Therapy
- Transcriptional Regulation
- Oncogenic Mutations
- Chemotherapy
- PET Imaging
- Metabolism
- Cell Cycle Control
- Ubiquitin
- PD-1 and PD-L1
- Immunotherapy
- Cell Migration
- Immunosuppression
- Phosphorylation
- Breast Cancer
- Signal Transduction
- Protein Kinases
- Targeted Therapy
- Protein-Protein Interactions
- PI3K/AKT pathway
- BRAF gene
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy18▲ 38×10 topics
- Tumor Microenvironment12▲ 33×6 topics
- Transcriptional Regulation10▲ 71×4 topics
- Cancer8▲ 7.3×18 topics
- Oncogenic Mutations6▲ 253×2 topics
- Cancer Progression5▲ 36×5 topics
- Chemotherapy5▲ 8.2×7 topics
- Cell Signaling5▲ 36×4 topics
- PET Imaging5▲ 34×2 topics
- Angiogenesis4▲ 17×5 topics
- Metabolism4▲ 10×6 topics
- Proteasome Inhibitors4▲ 80×2 topics
- Cell Cycle Control4▲ 151×2 topics
- Proteasome4▲ 148×1 topic
- Ubiquitin4▲ 148×1 topic
- Immune Checkpoint Blockade4▲ 43×1 topic
- PD-1 and PD-L14▲ 43×1 topic
- Calcineurin4▲ 404×1 topic
- Immunotherapy4▲ 6.7×9 topics
- NFAT4▲ 404×1 topic
- Cell Migration4▲ 97×3 topics
- Fibroblast Activation Protein4▲ 105×1 topic
- Immunosuppression4▲ 50×2 topics
- N-terminal Acetylation4▲ 105×1 topic
- Phosphorylation4▲ 181×2 topics
- Cell Proliferation3▲ 48×4 topics
- Breast Cancer3▲ 16×2 topics
- Molecular Chaperones3▲ 228×2 topics
- Signal Transduction3▲ 26×3 topics
- Immune Response3▲ 6.8×3 topics
- Protein Kinases3▲ 369×1 topic
- Ras Signaling3▲ 369×1 topic
- Targeted Therapy3▲ 17×4 topics
- Melanoma3▲ 57×2 topics
- Protein-Protein Interactions3▲ 81×2 topics
- Signaling3▲ 60×2 topics
- PI3K/AKT pathway3▲ 230×1 topic
- mTOR3▲ 230×1 topic
- BRAF gene3▲ 185×1 topic
- Mutation3▲ 19×3 topics
Which research topics does Revolution Medicines (United States) publish most on?
By volume in 2022-now: Ubiquitin and proteasome pathways, Cancer Immunotherapy and Biomarkers, Signaling Pathways in Disease and Peptidase Inhibition and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ubiquitin and proteasome pathways Molecular Biology 4 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 3 Signaling Pathways in Disease Molecular Biology 4 works
- 4 Peptidase Inhibition and Analysis Oncology 4 works
- 5 Protein Kinase Regulation and GTPase Signaling Molecular Biology 3 works
- 6 PI3K/AKT/mTOR signaling in cancer Molecular Biology 3 works
- 7 Melanoma and MAPK Pathways Molecular Biology 3 works
- 8 14-3-3 protein interactions Molecular Biology 2 works
- 9 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
- 10 Biochemical and Molecular Research Molecular Biology 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Revolution Medicines (United States)'s research output changed?
Output in 2022-2025 was 115% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Revolution Medicines (United States) as a percentage of every work published that year, 0.00039% in 2024.
Fractional works of Revolution Medicines (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Redwood City
- Heron Therapeutics (United States)
- Chan Zuckerberg Initiative (United States)
- Emergency University
- Guardant (United States)
- Box (United States)
- OncoMed (United States)
- Genomic Health (United States)
- Ubiquitous Energy (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Revolution Medicines (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
